$5.62
+0 (+0%)
At Close: Jan 05, 2026
Applied DNA Sciences, Inc. (APDN) Q3 2023 Earnings Call Transcript
05:59am, Saturday, 12'th Aug 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q3 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Sanjay Hurry - Head of IR Beth Jantzen - CFO James Hayward - Chairman, Presid
STONY BROOK, NY / ACCESSWIRE / August 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announc
3 Penny Stocks to Buy Before the Breakout
06:24pm, Thursday, 27'th Jul 2023
Investors tend to have a love-hate relationship with penny stocks. On the one hand, they offer the possibility of fascinating returns, due to the underlying stock's volatility, and the ability to purc
Best Penny Stocks to Buy? 5 To Watch With Big News
01:56pm, Thursday, 13'th Jul 2023
Something that has become one of the go-tos for traders is stock market news. That goes for anything from penny stocks to mega-caps like Apple or Tesla.
Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference
11:00am, Thursday, 08'th Jun 2023
STONY BROOK, NY / ACCESSWIRE / June 8, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in PCR-based DNA technologies, today announced that it has been invited to present at t
Applied DNA Sciences, Inc. (APDN) Q2 2023 Earnings Call Transcript
10:54pm, Thursday, 11'th May 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q2 2023 Results Earnings Conference Call May 12, 2023 4:30 PM ET Company Participants Sanjay Hurry - Head of Investor Relations Beth Jantzen - Chief Financial
Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023
03:00pm, Wednesday, 03'rd May 2023
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technolog
What Makes Applied DNA Sciences (APDN) a New Buy Stock
05:00pm, Wednesday, 15'th Feb 2023 Zacks Investment Research
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Applied DNA Sciences (APDN) a New Buy Stock
01:33pm, Wednesday, 15'th Feb 2023
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Applied DNA Sciences, Inc. (APDN) Q1 2023 Earnings Call Transcript
08:59pm, Thursday, 09'th Feb 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q1 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Sanjay Hurry - Investor Relations Beth Jantzen - Chief Financial Officer Jam
STONY BROOK, N.Y.--( BUSINESS WIRE )--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announ
Applied DNA Sciences, Inc. (APDN) Q4 2022 Earnings Call Transcript
07:57pm, Friday, 16'th Dec 2022
Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q4 2022 Earnings Conference Call December 14, 2022 4:30 PM ET Company Participants Sanjay Hurry - Investor Relations Beth Jantzen - Chief Financial Officer Ja
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
10:00am, Monday, 12'th Dec 2022
STONY BROOK, N.Y.--( BUSINESS WIRE )--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it plans to release its fiscal 2022 fo
RBC Bearings (RBC) Q2 Earnings and Revenues Top Estimates
02:25pm, Thursday, 10'th Nov 2022 Zacks Investment Research
RBC Bearings (RBC) delivered earnings and revenue surprises of 7.82% and 2.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Alta Equipment (ALTG) Q3 Earnings and Revenues Surpass Estimates
11:25pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Alta Equipment (ALTG) delivered earnings and revenue surprises of 16.67% and 5.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Sign In
Buy APDN